NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
This Quarter Return
-7.49%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
–
10 Year Return
–
AUM
$211M
AUM Growth
+$211M
Cap. Flow
-$102M
Cap. Flow %
-48.25%
Top 10 Hldgs %
84.11%
Holding
64
New
9
Increased
4
Reduced
8
Closed
19

Top Buys

1
TRDA icon
Entrada Therapeutics
TRDA
$1.63M
2
REPL icon
Replimune Group
REPL
$1.27M
3
CCXI
ChemoCentryx, Inc.
CCXI
$898K
4
TSVT
2seventy bio
TSVT
$687K
5
AFMD
Affimed
AFMD
$355K

Top Sells

1
NFH
New Frontier Health Corporation Ordinary Shares
NFH
$95.7M
2
NFH.WS
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
$4.27M
3
TVTX icon
Travere Therapeutics
TVTX
$1.51M
4
ASND icon
Ascendis Pharma
ASND
$989K
5
BLUE
bluebird bio
BLUE
$783K

Sector Composition

1 Healthcare 98.98%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ILMN icon
1
Illumina
ILMN
$15.8B
$45.3M 21.48%
129,647
– –
HRMY icon
2
Harmony Biosciences
HRMY
$2.12B
$37.4M 17.74%
768,708
– –
KRTX
3
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$29.8M 14.12%
234,811
– –
EAR
4
DELISTED
Eargo, Inc. Common Stock
EAR
$15.3M 7.24%
2,886,724
– –
SLGC
5
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$13.6M 6.45%
1,696,558
– –
EXAI
6
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$11.1M 5.26%
770,200
– –
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
$6.78M 3.22%
47,096
+1,756
+4% +$253K
RANI icon
8
Rani Therapeutics
RANI
$24.4M
$6.66M 3.16%
493,584
– –
XENE icon
9
Xenon Pharmaceuticals
XENE
$2.98B
$6.05M 2.87%
197,880
– –
VIR icon
10
Vir Biotechnology
VIR
$686M
$5.42M 2.57%
210,563
– –
BOLT icon
11
Bolt Biotherapeutics
BOLT
$9.85M
$3.2M 1.52%
1,166,952
– –
BEAM icon
12
Beam Therapeutics
BEAM
$1.66B
$3.15M 1.49%
54,903
– –
INCY icon
13
Incyte
INCY
$16.5B
$2.73M 1.3%
34,391
-119
-0.3% -$9.45K
ONC
14
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$2.27M 1.08%
12,022
+817
+7% +$154K
OTIC
15
DELISTED
Otonomy, Inc.
OTIC
$2.04M 0.97%
851,080
+80
+0% +$192
SRRA
16
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.7M 0.81%
52,979
– –
TRDA icon
17
Entrada Therapeutics
TRDA
$208M
$1.63M 0.77%
+173,582
New +$1.63M
GRTX
18
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.46M 0.69%
613,223
– –
EXEL icon
19
Exelixis
EXEL
$10.1B
$1.46M 0.69%
64,200
– –
PACB icon
20
Pacific Biosciences
PACB
$393M
$1.32M 0.63%
144,840
-26,920
-16% -$245K
REPL icon
21
Replimune Group
REPL
$422M
$1.27M 0.6%
+74,479
New +$1.27M
NVTA
22
DELISTED
Invitae Corporation
NVTA
$1.24M 0.59%
156,004
-1,858
-1% -$14.8K
EXAS icon
23
Exact Sciences
EXAS
$8.98B
$1.22M 0.58%
17,464
– –
KALV icon
24
KalVista Pharmaceuticals
KALV
$678M
$1.16M 0.55%
78,720
– –
CCXI
25
DELISTED
ChemoCentryx, Inc.
CCXI
$898K 0.43%
+35,830
New +$898K
1
2 3